Annual FCF
-$1.45 M
-$1.95 M-391.54%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual free cash flow is -$1.45 million, with the most recent change of -$1.95 million (-391.54%) on December 31, 2023.
- During the last 3 years, BGLC annual FCF has fallen by -$1.58 million (-1206.79%).
- BGLC annual FCF is now -391.54% below its all-time high of $497.70 thousand, reached on December 31, 2022.
Performance
BGLC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.66 M
-$986.30 K-146.68%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly free cash flow is -$1.66 million, with the most recent change of -$986.30 thousand (-146.68%) on September 30, 2024.
- Over the past year, BGLC quarterly FCF has dropped by -$986.30 thousand (-146.68%).
- BGLC quarterly FCF is now -319.78% below its all-time high of $754.70 thousand, reached on September 1, 2020.
Performance
BGLC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$2.65 M
-$625.40 K-30.89%
September 30, 2024
Summary
- As of February 7, 2025, BGLC TTM free cash flow is -$2.65 million, with the most recent change of -$625.40 thousand (-30.89%) on September 30, 2024.
- Over the past year, BGLC TTM FCF has dropped by -$625.40 thousand (-30.89%).
- BGLC TTM FCF is now -316.65% below its all-time high of $1.22 million, reached on March 1, 2021.
Performance
BGLC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BGLC Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -391.5% | -146.7% | -30.9% |
| 3 y3 years | -1206.8% | -1322.6% | -687.6% |
| 5 y5 years | -362.5% | -1322.6% | -687.6% |
BGLC Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -391.5% | at low | -444.3% | at low | -534.4% | at low |
| 5 y | 5-year | -391.5% | at low | -319.8% | at low | -316.6% | at low |
| alltime | all time | -391.5% | at low | -319.8% | at low | -316.6% | at low |
BioNexus Gene Lab Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.66 M(+146.7%) | -$2.65 M(+30.9%) |
| Jun 2024 | - | -$672.40 K(+1092.2%) | -$2.02 M(+45.6%) |
| Mar 2024 | - | -$56.40 K(-78.5%) | -$1.39 M(-4.1%) |
| Dec 2023 | -$1.45 M(-391.5%) | -$262.80 K(-74.6%) | -$1.45 M(+99.2%) |
| Sep 2023 | - | -$1.03 M(+2605.0%) | -$728.40 K(-219.4%) |
| Jun 2023 | - | -$38.20 K(-67.2%) | $610.10 K(+35.3%) |
| Mar 2023 | - | -$116.60 K(-125.4%) | $451.00 K(-9.4%) |
| Dec 2022 | $497.70 K(+8195.0%) | $459.70 K(+50.6%) | $497.60 K(-4.2%) |
| Sep 2022 | - | $305.20 K(-254.7%) | $519.60 K(-1.9%) |
| Jun 2022 | - | -$197.30 K(+181.9%) | $529.90 K(-396.7%) |
| Mar 2022 | - | -$70.00 K(-114.5%) | -$178.60 K(-3076.7%) |
| Dec 2021 | $6000.00 | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $481.70 K(+52.7%) | $6000.00(-83.1%) |
| Sep 2021 | - | $315.50 K(-134.8%) | $35.50 K(-92.5%) |
| Jun 2021 | - | -$905.80 K(-890.4%) | $474.70 K(-61.2%) |
| Mar 2021 | - | $114.60 K(-77.6%) | $1.22 M(+833.8%) |
| Dec 2020 | $131.10 K(-157.0%) | $511.20 K(-32.3%) | $131.00 K(-129.4%) |
| Sep 2020 | - | $754.70 K(-580.1%) | -$445.70 K(-64.5%) |
| Jun 2020 | - | -$157.20 K(-83.9%) | -$1.25 M(+9.6%) |
| Mar 2020 | - | -$977.70 K(+1392.7%) | -$1.14 M(+397.4%) |
| Dec 2019 | -$230.10 K(-26.6%) | -$65.50 K(+21.5%) | -$230.10 K(+39.8%) |
| Sep 2019 | - | -$53.90 K(+13.5%) | -$164.60 K(+48.7%) |
| Jun 2019 | - | -$47.50 K(-24.8%) | -$110.70 K(+75.2%) |
| Mar 2019 | - | -$63.20 K | -$63.20 K |
| Dec 2018 | -$313.70 K | - | - |
FAQ
- What is BioNexus Gene Lab annual free cash flow?
- What is the all time high annual FCF for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual FCF year-on-year change?
- What is BioNexus Gene Lab quarterly free cash flow?
- What is the all time high quarterly FCF for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly FCF year-on-year change?
- What is BioNexus Gene Lab TTM free cash flow?
- What is the all time high TTM FCF for BioNexus Gene Lab?
- What is BioNexus Gene Lab TTM FCF year-on-year change?
What is BioNexus Gene Lab annual free cash flow?
The current annual FCF of BGLC is -$1.45 M
What is the all time high annual FCF for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual free cash flow is $497.70 K
What is BioNexus Gene Lab annual FCF year-on-year change?
Over the past year, BGLC annual free cash flow has changed by -$1.95 M (-391.54%)
What is BioNexus Gene Lab quarterly free cash flow?
The current quarterly FCF of BGLC is -$1.66 M
What is the all time high quarterly FCF for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly free cash flow is $754.70 K
What is BioNexus Gene Lab quarterly FCF year-on-year change?
Over the past year, BGLC quarterly free cash flow has changed by -$986.30 K (-146.68%)
What is BioNexus Gene Lab TTM free cash flow?
The current TTM FCF of BGLC is -$2.65 M
What is the all time high TTM FCF for BioNexus Gene Lab?
BioNexus Gene Lab all-time high TTM free cash flow is $1.22 M
What is BioNexus Gene Lab TTM FCF year-on-year change?
Over the past year, BGLC TTM free cash flow has changed by -$625.40 K (-30.89%)